FDA backlog keeps generics from coming to market

Diane Archer
JustCareUSA.org

In October 2015, there were as many as 3,000 generic drugs waiting to be approved by the Food and Drug Administration. FDA underfunding may explain it in part. So might incomplete information on applications by their manufacturers as the FDA claims. But, whatever the reason, the result is that we end up paying high drug prices, (though some generic drug prices are sky high.)

Generics can cost as little as 20 percent of what brand-name drugs cost; they can also cost a lot more. Around 8 out of 10 prescriptions are for generic drugs but they account for less than 30 percent of our drug spending.

Read the full article at JustCareUSA.org →


Diane Archer JustCareUSA.org

Diane Archer JustCareUSA.org

Diane Archer is founder and CEO of JustCareUSA.org, a digital platform for baby boomers and carers. She began her career in health advocacy in 1989 as the founder and president of the Medicare Rights Center.


Did you find this article helpful?


Latest News

Breaking News – EpiPen Malfunction

Breaking News – EpiPen Malfunction

Just released from the FDA – Pfizer has informed the FDA that they are aware of several continuing problems that people are having using the EpiPen (epinephrine) and EpiPen Jr (epinephrine) auto-injectors and generic versions. Some of the problems are from user error and some from EpiPen malfunction. Here are…

ACE Inhibitors in the Time of Coronavirus

ACE Inhibitors in the Time of Coronavirus

Are you worried about ACE inhibitors and coronavirus? You may be hearing that one of the entry methods for the coronavirus in humans is by attaching to the ACE-2 enzyme. This has raised alarms among those with heart disease who use ACE inhibitors (with names ending in -pril, such as…

  • Advertisement